|Articles|August 2, 2016
OmniComm Signs Agreement with Research University
OmniComm Systems announced that it has signed an agreement with one of the top five medical research universities in the United States.
Advertisement
OmniComm Systems announced that it has signed an agreement with one of the top five medical research universities in the United States. The university plans to use OmniComm’s TrialMaster EDC and related services to conduct a series of clinical studies over a period of five years.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: De-Identified RWE Gains Ground, HHS Funding Stabilizes Research, and US Finalizes WHO Exit
2
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
3
ACT Brief: Decentralized Innovation Faces Reality, RWE Finds Its Lane, and Clinical Ops Reset for 2026
4
ESG as a Quality System: Practical Steps to Embed Sustainability Into Vendor Oversight
5